Cheryl Cho-Phan
Academic Appointments
- Clinical Assistant Professor, Medicine - Oncology
Key Documents
Contact Information
-
Clinical Offices
GI Oncology Clinic 875 Blake Wilbur Drive, Clinic F Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 736-4167
- Academic Offices
Personal Information Tel (650) 498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> GI Oncology
- Gastrointestinal Cancers
- Medical Oncology
- Oncology (Cancer)
Professional Education
| Residency: | Oregon Health Sciences Univ Hospital OR (1999) |
| Fellowship: | Stanford University School of Medicine CA (2002) |
| Medical Education: | Georgetown University Hospital DC (1996) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Clinical Trials
- Recruiting ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
- Not Recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
- Not Recruiting Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
Publications
- A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer. Clin Cancer Res. 2008; (21): 7074-9
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004; (4): 1017-21
- Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies. Clin Cancer Res. 2003; (14): 5187-94
- Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys. 2003; (1): 132-7
Help